Dockside LLC Acquires New Stake in Sabra Healthcare REIT, Inc. $SBRA

Dockside LLC acquired a new stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) during the fourth quarter, Holdings Channel reports. The fund acquired 102,438 shares of the real estate investment trust’s stock, valued at approximately $1,940,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in SBRA. Focus Partners Wealth lifted its holdings in Sabra Healthcare REIT by 11.4% in the 1st quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock valued at $404,000 after purchasing an additional 2,375 shares in the last quarter. EverSource Wealth Advisors LLC lifted its holdings in Sabra Healthcare REIT by 150.7% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock valued at $47,000 after purchasing an additional 1,536 shares in the last quarter. First Trust Advisors LP lifted its holdings in Sabra Healthcare REIT by 27.2% in the 2nd quarter. First Trust Advisors LP now owns 368,383 shares of the real estate investment trust’s stock valued at $6,793,000 after purchasing an additional 78,709 shares in the last quarter. Cerity Partners LLC lifted its holdings in Sabra Healthcare REIT by 73.0% in the 2nd quarter. Cerity Partners LLC now owns 18,686 shares of the real estate investment trust’s stock valued at $345,000 after purchasing an additional 7,885 shares in the last quarter. Finally, Daiwa Securities Group Inc. lifted its holdings in Sabra Healthcare REIT by 3.1% in the 2nd quarter. Daiwa Securities Group Inc. now owns 83,889 shares of the real estate investment trust’s stock valued at $1,547,000 after purchasing an additional 2,557 shares in the last quarter. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Stock Up 1.3%

Shares of SBRA opened at $18.73 on Friday. Sabra Healthcare REIT, Inc. has a 52-week low of $17.17 and a 52-week high of $21.28. The company has a market capitalization of $4.72 billion, a PE ratio of 29.73, a price-to-earnings-growth ratio of 1.39 and a beta of 0.64. The stock has a fifty day simple moving average of $20.06 and a two-hundred day simple moving average of $19.68. The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The business had revenue of $211.74 million during the quarter, compared to the consensus estimate of $209.20 million. During the same period last year, the company earned $0.37 EPS. The company’s revenue for the quarter was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, equities analysts forecast that Sabra Healthcare REIT, Inc. will post 1.51 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 29th. Investors of record on Friday, May 15th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.4%. The ex-dividend date of this dividend was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 190.48%.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the company. Truist Financial raised their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a report on Friday, March 13th. Citigroup raised their target price on Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, February 18th. UBS Group raised their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 13th. Wall Street Zen raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Monday, May 18th. Finally, Cantor Fitzgerald raised their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research note on Monday, May 11th. Five analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $22.40.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.